Ryan Specialty (NYSE:RYAN) Issues Quarterly Earnings Results

Ryan Specialty (NYSE:RYANGet Free Report) announced its quarterly earnings results on Thursday. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.43 by $0.04, FiscalAI reports. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The company had revenue of $795.23 million for the quarter, compared to the consensus estimate of $781.44 million. During the same quarter last year, the company posted $0.39 earnings per share. The company’s revenue for the quarter was up 15.2% compared to the same quarter last year.

Here are the key takeaways from Ryan Specialty’s conference call:

  • Q1 results were strong — total revenue rose 15% to $795 million, adjusted EBITDA grew 15.7% to $232 million (margin 29.2%), adjusted EPS increased 20% to $0.47, and the company repurchased $40 million of stock.
  • Management cut its 2026 outlook to mid-single-digit organic growth (≈4–6%)100–150 basis points driven by significant property rate declines and intensified competition.
  • The firm is accelerating its AI and digital transformation, reporting material efficiency gains — e.g., submission turnaround in some workflows fell from ~24 hours to under 2 hours, facultative reinsurance reviews from ~2 hours to minutes, and faster quote speeds across programs.
  • Diversification via delegated authority and reinsurance is a growth driver — Ryan Re is approaching ~$2 billion in premium (including the Markel contribution), new alternative capital vehicles like RAC Re were launched, and underwriting management represents an expanding share of revenue.

Ryan Specialty Stock Performance

RYAN stock traded down $3.89 during midday trading on Friday, hitting $30.89. The stock had a trading volume of 5,971,982 shares, compared to its average volume of 2,135,527. The firm has a market capitalization of $8.16 billion, a price-to-earnings ratio of 73.54, a P/E/G ratio of 0.95 and a beta of 0.71. The stock has a 50-day simple moving average of $36.08 and a 200 day simple moving average of $46.46. Ryan Specialty has a 52 week low of $29.91 and a 52 week high of $72.50. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th will be given a $0.13 dividend. This represents a $0.52 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is 123.81%.

Analyst Upgrades and Downgrades

Several brokerages have commented on RYAN. Keefe, Bruyette & Woods lowered their price target on Ryan Specialty from $49.00 to $42.00 and set an “outperform” rating on the stock in a report on Friday. Bank of America lowered their price target on Ryan Specialty from $70.00 to $68.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Weiss Ratings downgraded Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, February 5th. Piper Sandler lowered their price target on Ryan Specialty from $43.00 to $35.00 and set a “neutral” rating on the stock in a report on Friday. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $42.00 price target on shares of Ryan Specialty in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $47.47.

Get Our Latest Research Report on Ryan Specialty

More Ryan Specialty News

Here are the key news stories impacting Ryan Specialty this week:

  • Positive Sentiment: Q1 results beat expectations — EPS $0.47 vs. $0.43 est.; revenue $795.2M, +15.2% YoY and above consensus. Management reported 11.8% organic revenue growth and strong profitability metrics (ROE ~46%). This provides fundamental backing for the business after the quarter. Business Wire: Q1 Results
  • Positive Sentiment: Keefe, Bruyette & Woods kept an “outperform” rating while lowering its price target to $42 (still implies sizable upside vs. current levels), offering some analyst support for the stock. Benzinga: KBW PT
  • Positive Sentiment: Board announced a quarterly dividend of $0.13/share (ex-div May 12; pay May 26), an annualized yield ~1.7% — modest income support for shareholders.
  • Neutral Sentiment: Earnings call transcript and additional coverage are available for detailed readouts of management commentary on growth drivers and expense trends — useful for assessing forward guidance and margin drivers. Seeking Alpha: Q1 Call Transcript
  • Neutral Sentiment: Multiple outlets (Zacks, Yahoo, MSN) ran summaries noting the beat and key metrics; these amplify visibility but add little new information beyond the press release and call. Zacks: Earnings Coverage
  • Negative Sentiment: Piper Sandler cut its price target from $43 to $35 and moved to “neutral” — this reduces some analyst-implied upside and likely pressured sentiment. Benzinga: Piper Sandler PT Cut
  • Negative Sentiment: Wells Fargo reaffirmed an “equal weight” stance but slashed its target from $42 to $31, leaving little upside relative to the current price and adding downside risk. Benzinga: Wells Fargo PT Cut

Insider Activity

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was acquired at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director directly owned 428,295 shares of the company’s stock, valued at $17,114,668.20. This represents a 6.33% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 52.03% of the company’s stock.

Institutional Trading of Ryan Specialty

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RYAN. Royal Bank of Canada increased its position in Ryan Specialty by 10.6% in the first quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock worth $4,406,000 after purchasing an additional 5,739 shares during the period. AQR Capital Management LLC increased its position in Ryan Specialty by 25.1% in the first quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after purchasing an additional 998 shares during the period. Goldman Sachs Group Inc. increased its position in Ryan Specialty by 46.3% in the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock worth $27,787,000 after purchasing an additional 119,055 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Ryan Specialty by 11.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock worth $24,586,000 after purchasing an additional 33,667 shares during the period. Finally, Creative Planning grew its position in shares of Ryan Specialty by 15.4% during the 2nd quarter. Creative Planning now owns 4,586 shares of the company’s stock worth $312,000 after buying an additional 613 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Further Reading

Earnings History for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.